New hope for tough lung cancer: experimental combos tested in 110 patients
NCT ID NCT04938817
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests new drugs, alone or combined with pembrolizumab, in people with extensive-stage small cell lung cancer that has stopped responding to initial therapy. About 110 participants will receive experimental treatments to see if they are safe and can shrink tumors. The goal is to find better second-line options for this aggressive cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center-Lung Cancer Center ( Site 4103)
Seoul, 05505, South Korea
-
Banner MD Anderson Cancer Center ( Site 0152)
Gilbert, Arizona, 85234, United States
-
Baptist Health Lexington-Research ( Site 0158)
Lexington, Kentucky, 40503, United States
-
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 3502)
Sankt Gallen, Canton of St. Gallen, 9000, Switzerland
-
Chungbuk National University Hospital ( Site 4106)
Cheongju-si, North Chungcheong, 28644, South Korea
-
Cleveland Clinic-Taussig Cancer Center ( Site 0166)
Cleveland, Ohio, 44195, United States
-
Cross Cancer Institute ( Site 3004)
Edmonton, Alberta, T6G 1Z2, Canada
-
GBUZ "SPb CRPCstmc(o)" ( Site 3705)
Saint Petersburg, Sankt-Peterburg, 197758, Russia
-
GBUZ LOKB-Oncology department #1 ( Site 3701)
Saint Petersburg, Sankt-Peterburg, 194291, Russia
-
Hollywood Private Hospital-Medical Oncology ( Site 4001)
Perth, Western Australia, 6009, Australia
-
Hospital Clinic de Barcelona ( Site 3404)
Barcelona, 08036, Spain
-
Hospital Universitari Vall d'Hebron-Oncology ( Site 3401)
Barcelona, 08035, Spain
-
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 3301)
Rozzano, Milano, 20089, Italy
-
Instituto Catalan de Oncologia - Hospital Duran i Reynals ( Site 3403)
L'Hospitalet de Llobregat, Catalonia, 08908, Spain
-
Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 3304)
Milan, 20141, Italy
-
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 3800)
Szolnok, Jász-Nagykun-Szolnok, 5004, Hungary
-
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 3100)
Vienna, 1210, Austria
-
Krasnoyarsk Regional Oncology Dispensary, Named after Krizhanovsky ( Site 3708)
Krasnoyarsk, Krasnoyarsk Krai, 660133, Russia
-
MFSMC-HJWCI-Oncology Research ( Site 0178)
Baltimore, Maryland, 21237, United States
-
Meir Medical Center. ( Site 3601)
Kfar Saba, 4428164, Israel
-
Monash Health-Oncology Research ( Site 4005)
Clayton, Victoria, 3168, Australia
-
N.N.Petrov Research Institute of Oncology-Department of Chemotherapy and Innovative Technologies ( Site 3703)
Saint Petersburg, Sankt-Peterburg, 197758, Russia
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 3900)
Warsaw, Masovian Voivodeship, 02-781, Poland
-
Northside Hospital-Northside Hospital Oncology Network ( Site 0156)
Atlanta, Georgia, 30342, United States
-
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0172)
Omaha, Nebraska, 68130, United States
-
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0179)
Omaha, Nebraska, 68130, United States
-
Ospedale San Raffaele-Oncologia Medica ( Site 3303)
Milan, 20132, Italy
-
Parkview Research Center at Parkview Regional Medical Center ( Site 0180)
Fort Wayne, Indiana, 46845, United States
-
Princess Margaret Cancer Centre ( Site 3003)
Toronto, Ontario, M5G 2M9, Canada
-
Rabin Medical Center-Oncology ( Site 3604)
Petah Tikva, 4941492, Israel
-
Rambam Health Care Campus-Oncology ( Site 3600)
Haifa, 3109601, Israel
-
Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 3702)
Saint Petersburg, Leningradskaya Oblast', 198255, Russia
-
Samsung Medical Center ( Site 4100)
Seoul, 06351, South Korea
-
Scientific research institution of oncology named after N.N. Petrov-Thoracic oncology ( Site 3704)
Saint Petersburg, 197758, Russia
-
Seoul National University Bundang Hospital-Medical Oncology ( Site 4104)
Seongnam, Kyonggi-do, 13620, South Korea
-
Seoul National University Hospital ( Site 4101)
Seoul, 03080, South Korea
-
Shaare Zedek Medical Center-Oncology ( Site 3602)
Jerusalem, 9103102, Israel
-
Sheba Medical Center-ONCOLOGY ( Site 3603)
Ramat Gan, 5265601, Israel
-
St Francis Cancer Center-Research Office ( Site 0167)
Greenville, South Carolina, 29607, United States
-
St. Marys Hospital Center ( Site 3000)
Montreal, Quebec, H3T 1M5, Canada
-
Standort Penzing der Klinik Ottakring-Abteilung für Atemwegs-und Lungenkrankheiten ( Site 3101)
Vienna, 1140, Austria
-
The Prince Charles Hospital-Oncology Clinical Trials ( Site 4003)
Brisbane, Queensland, 4032, Australia
-
UPMC Hillman Cancer Center ( Site 0177)
Pittsburgh, Pennsylvania, 15232, United States
-
University of Kentucky Chandler Medical Center-Medical Oncology ( Site 0157)
Lexington, Kentucky, 40536, United States
-
Virginia Cancer Institute ( Site 0169)
Richmond, Virginia, 23229, United States
-
Warminsko-Mazurskie Centrum Chorob Płuc w Olsztynie ( Site 3903)
Olsztyn, Warmian-Masurian Voivodeship, 10-357, Poland
-
Westmead Hospital-Department of Medical Oncology ( Site 4004)
Westmead, New South Wales, 2145, Australia
-
ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 3300)
Siena, Tuscany, 53100, Italy